NASDAQ: VVOS
Vivos Therapeutics Inc Stock Ownership - Who owns Vivos Therapeutics?

Insider buying vs selling

Have Vivos Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Bradford K. AmmanPAO2026-07-31250,000$0.41
$102.50kBuy
Ronald Kirk HuntsmanCEO2026-06-3085,910$0.58
$50.00kBuy
Michael C. Skaff10% Owner2026-03-31308,848$1.34
$413.86kBuy
Michael C. Skaff10% Owner2026-03-311,044,777$1.34
$1.40MBuy

1 of 1

VVOS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VVOS insiders and whales buy or sell their stock.

VVOS Shareholders

What type of owners hold Vivos Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gurdev Dave Singh16.00%3,219,705$315.53kInsider
Michael C. Skaff13.40%2,696,123$264.22kInsider
Ronald Kirk Huntsman9.40%1,891,661$185.38kInsider
Vco Investors 3 LLC6.73%1,353,625$132.66kInsider
Bradford K. Amman1.24%250,080$24.51kInsider
Gregg C. Johnson0.04%7,994$783.41Insider
Raymond James Financial Inc0.00%350$34.30Institution
Ubs Group Ag0.00%151$14.80Institution
Geode Capital Management LLC0.00%84$8.23Institution
Vanguard Capital Management LLC0.00%60$5.88Institution

1 of 3

VVOS vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VVOS0.00%46.82%Net Buying
IVF0.01%99.99%Net Selling
NXL0.00%100.00%
ICCM0.01%61.95%
ADGM0.01%99.99%Net Buying

Vivos Therapeutics Stock Ownership FAQ

Who owns Vivos Therapeutics?

Vivos Therapeutics (NASDAQ: VVOS) is owned by 0.00% institutional shareholders, 46.82% Vivos Therapeutics insiders, and 53.18% retail investors. Gurdev Dave Singh is the largest individual Vivos Therapeutics shareholder, owning 3.22M shares representing 16.00% of the company. Gurdev Dave Singh's Vivos Therapeutics shares are currently valued at $264.02k.

If you're new to stock investing, here's how to buy Vivos Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.